Skip Navigation



BJA Advance Access published online on September 14, 2007

British Journal of Anaesthesia, doi:10.1093/bja/aem261
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
99/5/632    most recent
aem261v1
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Yu, C. K.
Right arrow Articles by Irwin, M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, C. K.
Right arrow Articles by Irwin, M. G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Board of Management and Trustees of the British Journal of Anaesthesia 2007. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Remifentanil preconditioning confers delayed cardioprotection in the rat

C. K. Yu1, Y.-H. Li1,3, G. T. C. Wong1, T. M. Wong2 and M. G. Irwin1,*

1 Department of Anaesthesiology
2 Department of Physiology, The University of Hong Kong, Queen Mary Hospital, Room 424, Block K, Pokfulam Road, Hong Kong
3 Anhui Medical University, Hefei, China

* Corresponding author. E-mail: mgirwin{at}hkucc.hku.hk

Background: Preconditioning with remifentanil (RPC) provides immediate cardioprotection in rats via all three types of opioid (OP) receptor. This study sought to investigate whether remifentanil also confers delayed cardioprotection via OP receptors.

Methods: Male rats received preconditioning either by ischaemia (IPC; 5 min occlusion, 5 min reperfusionx3) or with remifentanil (RPC; 1, 5, 10, and 20 µg kg–1 min–1, 20 min infusion). After 24 h, all animals were subjected to 30 min occlusion of the left coronary artery and 2 h of reperfusion. Subsequently, the time-course effect of RPC (10 µg kg–1 min–1, 20 min infusion) was determined at 12, 16, 24, 32, 36, and 48 h intervals, using the same experimental procedure. The effect of RPC (10 µg kg–1 min–1, 20 min infusion) and IPC in the presence of selective OP receptor antagonists was evaluated at the 24 h interval. Infarct size (IS), as a percentage of the area at risk (AAR), was determined.

Results: Pre-treatment with remifentanil at 1, 5, 10, and 20 µg kg–1 min–1 significantly reduced the IS/AAR at 24 h with the maximum effect at 10 µg kg–1 min–1. Remifentanil at 10 µg kg–1 min–1 significantly reduced the IS at 12 h [32.5 (SD 9.1)%]; 16 h [26.1 (2.8)%]; 24 h [19.5 (5.0)%]; 32 h [31.2 (9.1)%]; and 36 h [36.4 (9.4)%] after drug administration. The maximal reduction in IS was seen at 24 h and the effect completely disappeared at 48 h [36.4 (9.4)%]. The protective effect of RPC was abolished or significantly attenuated by blockade of any of the three OP receptors with selective antagonists.

Conclusions: Like IPC, remifentanil produces delayed cardioprotection in anaesthetized rats 12–36 h after administration. The protective effect is mediated via all three OP receptors.

Keywords: analgesics opioid, remifentanil; heart, ischaemia; rat; receptors, opioid


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Br J AnaesthHome page
J. Frassdorf, S. De Hert, and W. Schlack
Anaesthesia and myocardial ischaemia/reperfusion injury
Br. J. Anaesth., July 1, 2009; 103(1): 89 - 98.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
M. Zaugg
Is protection by inhalation agents volatile? Controversies in cardioprotection
Br. J. Anaesth., November 1, 2007; 99(5): 603 - 606.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.